Delivery Order SPE2DB24D2003-SPE2DB25FXHB0
Award Date
4/23/25
Potential Completion Date
4/24/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,251.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567985141 - TROKENDI XR 200 MG CAPSULE 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2025. The contract is not set aside for any specific business category. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,064.50 firm fixed-price delivery order is for the supply of 4566177898 TROKENDI XR 100 MG CAPSULE 30S, with an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,534.85, is for the delivery of TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of May 6, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, SPE2DB20D1100|SPE2DB25FZ43V, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp. The $1,707.24 firm fixed-price delivery order is for the pharmaceutical product TROKENDI XR 100 MG CAPSULE 30S, with a completion date of December 9, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,851.79 firm fixed-price delivery order is for the supply of TROKENDI XR 200 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FB4D6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,172.70 and is a Firm Fixed Price Delivery Order contract for the supply of TROKENDI XR 100 MG CAPSULE 30S. The contract has an ultimate completion date of March 31, 2025 and was awarded on March 28, 2025. This contract is not designated as a...
This federal contract award is a delivery order worth $3,079.88 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, identified as SPE2DB20D2104/SPE2DB23FS09Q, is a Delivery Order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,788.99 and covers the delivery of 4559862500 TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product. The contract award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,436.67 firm fixed-price delivery order is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product, with a completion date of November 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of TROKENDI XR 100 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The $2,283.05 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 12, 2024 and was awarded on June 11, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...